ER stress coupled pannexin channel activation via STIM proteins by Bodalia, Ankur
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
9-13-2013 12:00 AM 
ER stress coupled pannexin channel activation via STIM proteins 
Ankur Bodalia 
The University of Western Ontario 
Supervisor 
Dr. Michael F. Jackson 
The University of Western Ontario Joint Supervisor 
Dr. John F. MacDonald 
The University of Western Ontario 
Graduate Program in Pharmacology and Toxicology 
A thesis submitted in partial fulfillment of the requirements for the degree in Master of Science 
© Ankur Bodalia 2013 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Medical Pharmacology Commons, Medical Physiology Commons, and the Neurosciences 
Commons 
Recommended Citation 
Bodalia, Ankur, "ER stress coupled pannexin channel activation via STIM proteins" (2013). Electronic 
Thesis and Dissertation Repository. 1623. 
https://ir.lib.uwo.ca/etd/1623 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
	   	  	   	  
	   i 
 
ER STRESS COUPLED PANNEXIN CHANNEL ACTIVATION  
VIA STIM PROTEINS 
 
 
 
(Thesis format: Monograph) 
 
 
 
by 
 
 
 
Ankur Bodalia 
 
 
 
 
Graduate Program in Pharmacology 
 
 
 
 
A thesis submitted in partial fulfillment 
of the requirements for the degree of  
Master of Science 
 
 
 
 
The School of Graduate and Postdoctoral Studies 
The University of Western Ontario 
London, Ontario, Canada 
 
 
 
 
© Ankur Bodalia 2013 
 	    
	   	  	   	  
	   ii 
Abstract 
 
Many neurodegenerative diseases, including Alzheimer’s Disease, are associated with ER 
stress. It is suggested that plasma membrane channels contribute to the increased ionic 
influx and subsequent cell death in response to ER stress.  Pannexin channels, which have 
been implicated in various pathophysiological conditions, are a suitable candidate for 
facilitating this response.  However, mechanisms of pannexin channel activation are 
poorly defined.  I investigated the potential regulation of pannexin activity by the ER 
stress sensor, STIM.  It was hypothesized that pannexin channel activation during ER 
stress is contingent on the recruitment of STIM proteins.  In neurons, pannexin activation 
was observed in response to pharmacological ER stressors as well as Aβ42.  Moreover, I 
identified STIM as a key signaling component promoting pannexin activation under ER 
stress in HEK cells, though not in neurons.  In conclusion, pannexin activation is coupled 
to ER stress in neurons; however, the underlying molecular mechanism remains 
unknown. 
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1.1 Overview of ER stress in neurodegenerative diseases 
Many neurodegenerative diseases, including Alzheimer’s Disease (AD), are associated 
with the misfolding of proteins, calcium (Ca2+) dysregulation and resultant apoptotic cell 
death. Whether these pathological processes are interrelated has remained an open 
question. Within a neuron, the organelle responsible for protein folding, and an important 
regulator of Ca2+ homeostasis, is the endoplasmic reticulum (ER).  In the context of 
neurodegenerative diseases, the ER has been shown to have exhausted its capacity to 
regulate Ca2+ homeostasis leading to an accumulation of misfolded and unfolded proteins 
otherwise known as ER stress.  ER stress markers have been found to be up-regulated at 
early stages in AD patients.  Moreover, ER stress has been proposed to contribute to β-
amyloid1-42-induced neurotoxicity, however the contributing mechanisms have not been 
precisely defined.    Pannexin, a large-pore channel soluble to solutes of up to 1 kDa, has 
been implicated in neuronal cell death and is a suitable candidate for studying ER stress 
mediated ionic influx. Moreover, a recent study has provided evidence suggesting that 
Aβ42 promotes activation of a large-pore channel, though its identity was not confirmed. 
Evidence from the Jackson/MacDonald labs suggests that ER stress is associated with 
pannexin channel opening.  This led us to propose that ER stress may be coupled to 
pannexin opening with Aβ42 treatment. In addition, as pannexin activation mechanisms 
are poorly understood, I investigated mechanisms by which neuronal ER stress is coupled 
to pannexin activation. 
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1.2 Pannexin channel structure and function 
The pannexin channel is a large-pore non-selective ion channel located on the plasma 
membrane of neurons.  Although pannexin channels were previously reported to localize 
to the ER (Penuela et al., 2007), those particular variants of pannexin have been identified 
as incomplete-glycosylation forms of pannexin, which fail to escape the ER for 
trafficking to the cell surface (Bhalla-Gehi et al., 2010).  The ER-retained forms of 
pannexin are thought to be destined for premature degradation by proteosomes, a view 
that is supported by its co-localization to calnexin, an ER chaperone that retains 
misfolded proteins for premature degradation (Gehi et al., 2011).  Rather than functioning 
as gap junctional hemichannels, pannexins operate individually as bona fide plasma 
membrane channels connecting cytoplasm to the extracellular space (MacVicar and 
Thompson, 2010).  Pannexin-1, first cloned in 2003, is the only ubiquitously expressed 
member of the pannexin family (Bruzzone et al., 2003). Pannexin-2 expression is 
predominantly confined to tissues of the central nervous system, whereas pannexin-3 is 
expressed in skin and bone (Baranova et al., 2004). The ability of pannexin-2 and 
pannexin-3 to form functional channels on their own has been debated, however when 
co-expressed with pannexin-1, heteromeric channels with their own distinct properties 
have been generated (Penuela et al., 2009).  Of the three, pannexin-1 is the most studied 
to date and the focal point of my experiments.  
Structurally, pannexin channels contain 4-transmembrane domains, an intracellular loop, 
intracellular N and C termini and highly conserved cysteine residues on two extracellular 
loops (Bruzzone et al, 2003).  The original view that pannexins functioned as gap 
junction hemichannels stemmed from their topological similarities to the gap junctional 
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Innexin protein family found in invertebrates (Phelan and Starich, 2001).  Pannexins have 
since been proven not to be gap junctional proteins based on the following conclusive 
evidence from various labs: 
• In a paired oocyte assay, transjunctional currents are prominent in connexin 
expressing pairs but absent in pannexin expressing pairs (Dahl et al., 1992; 
Bruzzone et al., 2003) 
• Pannexin-1 expression has been observed in single non-gap junction forming cells 
such as erythrocytes (Locovei et al., 2006) 
• In polarized non-symmetrical cells, pannexin-1 is found exclusively on the apical 
membrane which is not involved in cell-to-cell contact (Ransford et al., 2009) 
• In neurons, pannexin-1 is found exclusively at post-synaptic membranes and 
shows no sign of involvement in electrical synapses (Zoidl et al., 2007) 
With this evidence, pannexins are now widely accepted as large pore forming channels in 
the plasma membrane. A single pannexin channel is a hexamer of six subunits that allows 
non-selective permeation to ions and small molecules up to 1 kDa in size (Boassa et al., 
2007; Ambrosi et al., 2010).  This large pore size and non-selective permeability 
describes the unique nature of pannexin channels.  When describing ion channel 
selectivity, channels that are permeable to both cations and anions, pannexin channels for 
instance, are considered “non-selective”.  In addition to ion transport, pannexin channels 
have also been shown to release large metabolites such as ATP, as well as interleukins 
and glutamate (Bao et al., 2004; Jiang et al., 2007).  Two important studies have 
functionally classified pannexin channels as ATP-release channels, however, an upstream 
trigger for pannexin opening remains undetermined.  ATP release from pannexin-1 
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channels serves to induce vasodilation in erythrocytes under hypoxic conditions (Locovei 
et al., 2006).  Additionally, the same function was noted in apoptotic lymphocytes where 
the observed ATP release from pannexin channels serves as a “find me” signal for 
macrophages (Chekeni et al., 2010).  Given that ER stress markers are elevated in both 
apoptosis (Galehdar et al., 2010) and hypoxia (Tajiri et al, 2004), an ER stress triggered 
opening of pannexin channels could be a plausible mechanism underlying these 
observations. 
 
 
1.3 Functional identification of pannexin activity 
From reviewing literature on pannexin characterization, identification of pannexin-1 
channel activity involves a combination of biochemical assays, DNA 
overexpression/silencing, pharmacological inhibition and electrophysiological recordings. 
In addition to the main conductance state, four different sub-conductance states have been 
observed in single channel recordings from excised patches in pannexin-1 expressing 
oocytes (Bao et al., 2004).  Though not entirely agreed upon, some groups have 
characterized pannexin-1 whole cell currents as outward rectifying, activated at 
increasingly depolarized potentials (Ma et al., 2009). In this study, to reliably identify 
pannexin-1 channel activity and critical mediators in the activation pathway, I have 
paired RNA interference (RNAi) and DNA over-expression techniques with 
pharmacological characterization during electrophysiological recording of pannexin-1 
activity.   
Of the variety of known pharmacological inhibitors for pannexin-1, some of these 
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compounds overlap in their ability to block various non-selective cation channels (Table 
1).  For example, pannexin-1 blocker carbenoxolone is also known to block connexin 
hemichannels. Additionally, SKF96395, which does not block pannexin-1 channels, is 
known to block ORAI and TRPC channels.  These inhibitors, among others, are utilized 
to pharmacologically identify pannexin-1 currents using a combinatorial approach to 
rule-out connexin hemichannels and other non-selective cation channels but rule-in 
pannexin channels based on their differential sensitivity to blockers.  From the literature, 
pannexin-1 activity is inhibited by carbenoxolone (cbx) with an IC50 of 5 µM, and 
probenecid (prb) with an IC50 of 150 µM. Contrastingly, pannexin-1 is relatively 
insensitive to flufenamic acid (ffa) with an IC50 = 300 µM while connexins are more 
sensitive to inhibition by ffa with an IC50 of 3-100 µM but also relatively insensitive to 
cbx with an IC50 of 3-100 µM (D’hondt et al., 2009; Ma et al., 2009; Ma et al., 2012).  
Despite their effectiveness as an experimental tool, it is important to note that no single 
blocker is fully specific to pannexin-1 channels.  Thus, employing a combinatorial rule-
in/rule-out approach to identifying pannexin-1 activity in this study was the best means of 
avoiding this potential pitfall. 
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Table 1. Pharmacological profile of candidate non-selective cation channels 
I-V, current-voltage; NMDG+, N-methyl-D-glucamin; La3+, lanthanum, Ca2+, calcium; 
ECS, excellular solution; 10panx1, pannexin-1 inhibitory peptide; TRPM, transient 
receptor potential melastatin; TRPC, transient receptor potential cation; CRAC, calcium 
release-activated calcium  
 
 
One overlying objective of this project was to provide insight and rationale for exploring 
a role of pannexin channels in ER stress associated neurodegeneration. Since both 
pannexin channels and ER stress have individually been shown to contribute to cell death 
in a variety of cell types, including neurons, this study included experiments to determine 
whether pannexin channels were activated in response to treatment with Aβ42, a known 
inducer of ER stress. 
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1.4 Regulation of Ca2+ homeostasis by the ER 
The ER is a known regulator of intracellular signaling events, most notably intracellular 
Ca2+ homeostasis.  When a cell exhausts its capacity to regulate intracellular Ca2+, normal 
functions are lost and cell death proceeds (Orrenius et al., 2003).  Morphologically, the 
ER extends from dendritic spines, across the cell body, down the axon to the pre-synaptic 
terminal, which suggests an existing ER contribution to neurotransmitter release and gene 
transcription among other cellular functions (Verkhratsky and Peterson, 2002).  Aside 
from Ca2+ homeostasis, the ER serves many other well-characterized functions including 
post-translational protein processing as well as the facilitation of protein folding and 
transport (Burdakov et al., 2005).   Correct folding of newly synthesized proteins is aided 
by several ER chaperone proteins, most commonly binding-immunoglobulin protein 
(BiP), a heat shock protein family member.  Other notable ER chaperones include 
protein-disulfide-isomerase, calnexin and calreticulin.  Once folding is complete, the 
functional proteins are transported from the ER to the golgi complex (Truettner et al., 
2009).  Since ER chaperones are Ca2+ dependent, their activity is dictated by the 
intraluminal Ca2+ concentration of the ER (Michalak et al., 2002).  Therefore, 
dysregulation of ER Ca2+ stores and consequent impairment of ER chaperone function, 
results in an accumulation of unfolded and misfolded proteins.  This disturbance in 
protein folding characterizes a condition called ER stress (Ryu et al., 2002), a cellular 
correlate to the progression of neurodegenerative diseases.  In fact, the occurrence of 
cellular stressors that disrupt ER function increases with aging.  For example, elevated 
intracellular Ca2+ and reactive oxygen species can alter the balance of the cellular redox 
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environment to induce ER stress. This trend indicates that the aging brain is more 
susceptible to ER stress associated neuronal injury (Banhegyi et al., 2008). 
 
 
1.5  Cellular responses to ER stress 
An early cellular response to ER stress is the activation of a pro-survival mechanism that 
is a network composed of intracellular signaling and transcriptional changes known as the 
Unfolded Protein Response (UPR).  This biochemical cascade involves the coordinated 
activity of specific enzymes and transcription factors that alter conditions within the ER 
in an attempt to restore Ca2+ and protein homeostasis.  The prevailing actions of the UPR 
are to attenuate the rate at which mRNA is translated, up-regulate the expression of ER 
resident chaperones and foldases, mediate the expansion of the ER membrane to increase 
ER compartment space, and trigger ER-associated-degradation to eliminate misfolded 
proteins (Calfon et al., 2002).  Under severe or chronic ER stress, the UPR can stimulate 
an inflammatory signaling pathway and ultimately apoptosis when pro-survival efforts 
are exhausted (Harama et al., 2009).  In cases of ER stress where homeostasis can not be 
restored and the signaling pathways of the UPR subverts from pro-survival to pro-
apoptotic, fluorescent dyes have been used to monitor the well characterized increase in 
plasma membrane permeability observed in apoptotic cells (Puthalakath et al., 2007). 
Given the large pore size and non-selective permeability of pannexin channels, it is 
reasonable to consider them as the ion channel facilitating this observed response to ER 
stress. 
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ER stress markers that are commonly assayed for include the active, dimerized forms of 
PERK, IRE1 and ATF6 as well as upregulated ER stress responsive genes CHOP and 
other protein folding chaperones.  For the purpose of my thesis, ER stress markers and 
the signaling pathways of the UPR did not represent the focus of my experimental plan 
and are therefore not discussed in further detail.  Rather, the focus of my study was on the 
signaling of ER stress to the plasma membrane where a response of ion channel activity 
could be recorded. 
 
 
1.6 Store-Operated Ca2+ Entry, Stromal Interacting Molecules 
A recurring theme in many studies of ER stress is that depletion of ER Ca2+ stores is an 
important trigger for ER stress.  This can be enhanced through activation of ryanodine 
receptors and IP3 receptors on the ER, or conversely, the impairment of sarcoplasmic-
endoplasmic reticulum ATPase (SERCA) function.  Experimentally, depletion of ER 
stores through inhibition of SERCA activity is sufficient to initiate ER stress and cell 
death (Stutzmann and Mattson, 2011).  Typically, ER stress is defined on the basis of 
UPR induction.  However, UPR signaling is unlikely to represent the earliest response of 
the ER to cellular stressors, which includes depletion of ATP, loss of Ca2+ homeostasis 
and the generation of reactive oxygen species (ROS) (Kohno et al., 1994; Xing et al., 
2004).  ER chaperones and foldases being Ca2+ dependent makes correct protein folding 
in the ER contingent on luminal Ca2+ levels being maintained by steady refilling 
processes, thus avoiding activation of ER stress pathways.   
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Stromal-interacting molecules (STIM) proteins, which function as ER resident Ca2+ 
sensors, have recently been identified as important contributors to neuronal cell death 
post-ischemia where ER stress has been shown to occur and proceed to pro-apoptosis 
(Berna-Erro et al., 2009).  In the mid-1980s, it was proposed that when ER stores are 
depleted of Ca2+, a refilling process via Ca2+ influx from the extracellular environment, 
involving ER proteins and plasma membrane channels, is utilized (Putney, 1986).  This 
process has been termed store-operated Ca2+ entry (SOCE), alternatively referred to as 
capacitive calcium entry (CCE). Two STIM isoforms (STIM1 and STIM2) have recently 
been shown to act as Ca2+ sensors that relay messages of alterations in luminal Ca2+ to the 
plasma membrane (Liou et al., 2005).  Their direct interaction with Ca2+ influx channels 
at the plasma membrane is required for SOCE (Zhang et al., 2006). 
 
 
1.7  STIM structure and function 
The single-pass transmembrane proteins STIM1 and STIM2, originally named GOK and 
proposed to be involved in tumor suppression and modifications of cell morphology 
(Sabbioni et al., 1997), have a cytosolic C-terminal, whereas the N-terminal, responsible 
for Ca2+ detection, is in the ER lumen where Ca2+ is stored.  Functionally, STIM detects 
decreases in ER-luminal Ca2+ through Ca2+ binding EF-hand domains on the 
aforementioned luminal N-terminal.  At resting state, defined by a sufficient level of ER-
luminal Ca2+, the binding of Ca2+ to the intraluminal EF-hand domains of the N-terminal 
maintains STIM in its resting-dimeric conformation. Also at the N-terminal are dense 
clusters of sterile-α-motif (SAM) domains that function to stabilize STIM in a dimeric 
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form when EF-hands are Ca2+ bound (Stathopulos et al., 2006).   In the case of depleted 
Ca2+ stores, Ca2+ dissociates from the EF-hand domains of STIM, unfolding and 
destabilizing the EF-SAM clusters.  This promotes activation, wherein STIM dimers 
aggregate into oligomeric STIM complexes (Stathopulos et al., 2008).  Effectively, STIM 
behaves as a Ca2+ sensor and is responsible for relaying the status of ER Ca2+ stores to the 
plasma membrane.  Translocation of STIM along the ER membrane to ER-PM junctions 
enables STIM interaction with Ca2+ influx channels expressed at the cell surface to 
facilitate SOCE.   
 
The two isoforms, STIM1 and STIM2, possess homologous functional domains with the 
only differences between the two isoforms being slight variations in the amino acid 
sequences of their N and C termini.  Functional consequences of these variations are in 
their affinities for Ca2+ binding, thus affecting each isoform’s sensitivity of ER Ca2+ 
detection as well as activation kinetics and contribution to SOCE signaling (Zhou et al., 
2009).  The higher affinity isoform, STIM1, is regarded as the principal modulator of 
SOCE because it is rapidly activated under ER Ca2+ depletion (Roos et al., 2005), 
whereas the lower affinity STIM2, despite being more sensitive to ER Ca2+ depletion, 
demonstrates slower activation kinetics and is considered to be responsible for the very 
fine-tuning of ER Ca2+ concentrations (Brandman et al., 2007).   
 
Aside from sensing decreases in ER Ca2+ levels, STIM has also been regarded as a 
general cellular stress sensor because it is also activated by oxidative stress and transient 
temperature changes (Soboloff et al., 2012). In response to pathological ROS levels, S-
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glutathionylation of Cys56 on STIM, adjacent to its EF-SAM domains, causes a 
dissociation of Ca2+ from STIM and subsequent SOCE without ER Ca2+ depletion 
(Hawkins et al., 2010). Additionally, STIM1 has been shown to oligomerize and 
translocate to ER-PM junctions when cells are heated from 37 to 40oC.  Subsequent 
cooling back to 37oC triggers Ca2+ influx, independent of ER Ca2+ levels, thus 
implicating STIM as a sensor to transient temperature change as well (Xiao et al., 2011). 
So far, members of the ORAI, TRPC and L-type voltage-gated Ca2+ channel families 
have been identified as coupling targets for activated STIM (Feske et al., 2006; Huang et 
al., 2006; Wang et al., 2010).  Given that, the pannexin family of ion channels has been 
pathophysiologically implicated in various cellular responses associated with ER stress 
such as hypoxia, ischemia and apoptosis (Dahl and Keane, 2012), STIM is a suitable 
candidate to consider for coupling ER stress to pannexin channel activation (Fig.1.1).  
The focus of my thesis is to investigate the relationship between STIM and pannexin 
channels in the context of ER stress induced pannexin activation. 
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Figure 1.1 Proposed model of ER stress coupled pannexin activity, mediated by 
activate STIM proteins. 
A) At physiological levels of ER-Ca2+, STIM (yellow) remains in resting state as their 
intraluminal E-F hands bind Ca2+, stabilizing the structure. B) ER-Ca2+ depletion and 
subsequent accumulation of misfolded proteins in the ER, by inhibition of SERCA 
pumps for example, results in the dissociation of Ca2+ from STIM. Active STIM proteins 
will oligomerize and translocate to ER-PM junctions to interact with plasma membrane 
ion channels through their CAD domains (purple). 
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1.8 ER stress in Alzheimer’s Disease, beta-amyloid 
Neurodegenerative diseases share common pathological features such as the 
accumulation of misfolded proteins and loss of Ca2+ homeostasis. For this reason, ER 
stress is often studied in the context of neurodegeneration.  In particular, ER stress has 
been well defined in models of Alzheimer’s disease (AD), a fatal neurodegenerative 
disease characterized by progressive dementia and memory loss.  Miscleavage of the 
amyloid precursor protein in the brain by the gamma-secretase enzyme yields a 
neurotoxic species, beta-amyloid1-42 (Aβ42).  A long held view suggests that the 
deposition of Aβ42 into senile plaques, the hallmark of an Alzheimer’s brain at autopsy, is 
largely responsible for neurodegeneration.  However, plaque formation represents the 
endpoint of an aggregation process which leads to the formation of soluble oligomers, 
protofibrils and fibrils.  Importantly, recent studies suggest that the onset of cognitive 
decline in patients is better correlated with the occurrence of soluble oligomers rather 
than plaques (McLean et al., 1999; Mc Donald et al., 2010).  Accordingly, a recent focus 
has been to understand the mechanisms responsible for neurotoxicity induced by soluble 
oligomers of Aβ42, rather than the formation of plaques, and more specifically, to identify 
ion channel coupling downstream of Aβ42, a known inducer of ER stress. 
 
Various neurodegenerative diseases, including AD, Parkinson’s Disease and 
Huntington’s Disease, are associated with an accumulation of misfolded proteins causing 
a disruption in ER function, and in turn inducing ER stress (Urano et al., 2000; Imai et 
al., 2001; Holtz and O’Malley, 2003; Kaneko et al., 2010). In the context of AD at the 
cellular level, oligomers of Aβ42 disrupt Ca2+ homeostasis by altering the function of 
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ryanodine receptors and IP3 receptors on the ER membrane as well as various calcium 
permeable channels on the plasma membrane including voltage-gated Ca2+ channels, 
nicotinic acetylcholine receptors and glutamatergic receptors (reviewed by Demuro et al., 
2010). thereby causing ER stress and ultimately increasing neuronal vulnerability to 
apoptosis.  Other cellular stresses brought on by oligomers of Aβ42 include increased 
oxidative stress, disruption of synaptic plasticity, and altered synaptic structure 
(Townsend et al., 2006; De Felice et al., 2007).  Although, the mechanisms responsible 
for such changes are not well understood recent evidence suggests that Aβ42 may 
compromise neuronal viability by disrupting the function of the endoplasmic reticulum, 
leading to ER stress.  In AD studies, application of Aβ42 has been shown to increase the 
expression of ER stress responsive genes (Takahasi et al., 2009) and ER stress markers 
are detected at the early stages of AD in patients (Hoozemans et al., 2005; Unterberger et 
al., 2006).  Importantly, previous studies have shown that protecting the ER against stress 
attenuates Aβ42-mediated neurotoxicity (Lee do et al, 2010).  In behavioural studies, 
protection from ER stress has been shown to attenuate memory loss in mouse models of 
AD (Ricobaraza et al., 2010; Wiley et al., 2011). 
 
 
1.9 Rationale and hypothesis 
Preliminary studies from our lab strongly imply that pannexin channels are activated 
downstream of ER stress. In these experiments, ion currents were characterized through 
whole-cell voltage-clamp recordings from pyramidal CA1 hippocampal neurons exposed 
acutely to commonly used ER stressors.  Thapsigargin (Tg) and cyclopiazonic acid 
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(CPA), although different in structure, are both sarcoplasmic-endoplasmic-reticulum-
Ca2+-ATPase (SERCA) inhibitors which were applied to neurons to prevent depleted ER 
Ca2+ stores from being replenished, effectively inducing ER stress (Nguyen et al., 2002). 
Furthermore, neurons were exposed to tunicamycin (Tn), an inhibitor of N-glycosylation, 
which decreases the post-translational protein processing typically facilitated by the ER 
(Shiraishi et al., 2005).  The consequent accumulation of unprocessed proteins in the ER 
initiates ER stress.  The observed current was classified as emanating from pannexin 
channels on the basis of biophysical and pharmacological profiles.  Supporting our view 
was the inhibition of this ER stress-induced current by known pannexin blocking agents 
such as lanthanum (La3+), carbenoxolone, probenecid and 10panx-inhibitory peptide, as 
well as its insensitivity to ORAI and TRPC blocker SKF96365 and removal of Ca2+ from 
extracellular solution.  What remained to be identified is a mechanism responsible for 
activating pannexin channels in response to ER stress.  One candidate mechanism 
through which an ER stress signal is relayed to pannexin channels expressed at the cell 
surface is via coupling with ER-resident STIM proteins, an essential contributor to the 
refilling of ER Ca2+ stores upon depletion. 
 
The primary objective of my thesis was to establish the mechanisms through which ER 
stress provokes pannexin activation.  I hypothesize that pannexin channel activation 
during ER stress is contingent on the recruitment of STIM proteins. 
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Section 2 
 
MATERIALS AND METHODS 	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2.1  Preparation of primary cultured mouse hippocampal neurons 
All postnatal hippocampal cell cultures were prepared by technicians from the 
Jackson/MacDonald lab as previous described (MacDonald et al., 1989).  In short, 
embryonic mouse pups were harvested at embryonic day 17-18, and the hippocampi of 
each were dissected and isolated.  Neurons were dissociated by mechanical trituration 
using pasteur pipettes and the cells were plated on poly-D-lysine coated petri dishes at a 
plating of density of approximately 50% confluency, approximately 1 million cells per 
plate.  These cultures were incubated in neurobasal culture media, supplemented with B-
27 and glucose, at 37oC in 5% carbon dioxide.  Media was replenished every 3-4 days.  
Electrophysiological recordings were performed on cultured hippocampal neurons after 
14-21 days in vitro (DIV). 
 
Knockdown of STIM1 and STIM2 was conducted using lentivirus to infect cultured 
hippocampal neurons with STIM1 shRNA  and/or STIM2 shRNA or scrambled shRNA 
as control.  Expression of the shRNA was driven by a u6 promotor.  Also expressed on 
the same transfer vector, pLB, was green florescent protein (GFP), which was driven by a 
CMV promotor.  Infecti was performed on cultured neurons 3-5 DIV and 
electrophysiological recordings were performed  14-21 DIV. 
 
 
2.2 Preparation of pannexin and STIM expressing HEK 293 cells 
A cell line of HEK 293 cells stably expressing a tetracycline-inducible pannexin-1 
encoding gene “flag-mPanx1”, generated by the Jackson lab, was passaged bi-weekly.  
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Cells were cultured in 100 mm petri dishes and grown in FBS enriched D-MEM, 
incubated at 37oC in 5% carbon dioxide. Transient co-transfections of DNA expression 
plasmids for STIM1 and/or STIM2 as well as GFP were performed on flag-mPanx1 HEK 
293 cells using the JetPrime transfection system (Polyplus) prior to electrophysiological 
recording.  To control for the contribution of endogenous STIM expression in some 
experiments, RNA-silencing vectors targeting STIM1 and STIM2 were also transfected.  
For experiments involving mutated STIM proteins, DNA expressing an 
ezrin/radixin/moesin (ERM) domain deleted variant of STIM1 (STIM1ΔERM) was used 
(Fig. 2.1). Briefly, flag-mPanx1 HEK 293 cells were seeded in 6-well plates, 24 hours 
prior, to yield optimal transfection confluence of 60-80%.  Transfection mixes were 
composed of 200 µL JetPrime buffer, 2 µg total DNA, 2.5 µL JetPrime transfection 
reagent.  2 µg of total DNA to be transfected included combinations of DNA vectors 
encoding GFP, STIM1 (in pCDNA3.1), STIM2 (in pCDNA3.1), shRNA targeting 
STIM1 expression “pLB(mCherry)-mSTIM1-hp4”, shRNA targeting STIM2 expression 
gene “pLB(GFP)-mSTIM2-hp4”, a mutated variant STIM1ΔERM (in pIRES) and empty 
vector “pCDNA3.1” (Invitrogen).  Transfection mixes were incubated at room 
temperature for 10 minutes, vortexed for 10 seconds, and added drop wise to flag-
mPanx1 HEK 293 cells.  Following 4 hours of incubation at 37oC in 5% carbon dioxide, 
transfection media was replaced with fresh media.  Cells were re-seeded on 35 mm petri 
dishes 24 hours post-transfection at a plating density of 20% for next-day recording or 
10% for day-two recordings.  Upon plating, 1 µg/mL doxycycline was added to media to 
induce pannexin-1 expression. 
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Figure 2.1 Representation of the full length STIM1 protein (above) and the ERM 
domain deletion in STIM1ΔERM variant (below). 
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2.3  Preparation of oligomeric Aβ42 peptides 
Solid Aβ42 peptides (rPeptide, catalogue no. A-1002-2) stored at -80oC, were equilibrated 
to room temperature before hexaflouro-2-propanol (HFIP) solvent was added, on ice, to a 
peptide concentration of 1 mM.  After 1 hour of incubation at room temperature with 
intermittent vortexing to achieve complete dissolution, peptide solutions were placed 
back on ice for 5-10 minutes. Aβ42 solution was aliquoted in 10 µL samples and HFIP 
solvent was removed by Speedvac dry down for 10 minutes at 37oC, then placed in -20oC 
for 2 hours, followed by storage at -80oC leaving only peptide biofilms of Aβ1-42 
monomers.  To oligomerize, fresh anhydrous DMSO was added to a concentration of 1 
mM Aβ42 and vortexted, yielding a final concentration of 100 µL.  Solutions were 
sonicated for 10 minutes at 37oC then diluted 10-fold in PBS and mixed well.  Final 
incubation at 4oC for 24 hours is when oligomerization occurred yielding soluble 
oligomers of Aβ42, stable at -80oC for up to 2 weeks. 
Application of soluble oligomers of Aβ42 to primary hippocampal neuron cultures was 
done 24 hours prior to electrophysiological recording at a final peptide concentration of 1 
µM in media and incubated at 37oC in 5% carbon dioxide. 
 
 
2.4  Electrophysiology: whole-cell patch-clamp recordings 
Pyramidal hippocampal neurons were identified under a microscope by cell shape, with 
candidate neurons having a triangular shaped cell body, phase-bright contrast, and 
healthy re-formed non-fractioned processes (Fig. 2.2).  For HEK cells, UV light exposure 
to excite fluorescence in successfully transfected cells was used to visually identify 
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candidate cells with expression of pannexin-1 and STIM based on GFP and/or Cherry co-
expression.  Petri dish media was replaced with artificial extracellular solution containing 
(in mM): 130 NaCl, 25 HEPES buffer, 10 D-Glucose, 10 tetraethylammonium (TEA), 5.4 
KCl, 2 CaCl2 and 1 MgCl2 adjusted to pH 7.4 with NaOH. The following channel 
blockers were included in recordings of neurons only (in µM): 500 4-aminopyradine (4-
AP), 0.2 tetrodotoxin (TTX), 50 CdCl2, 10 bicuculline, 10 cyano-nitroquinoxaline-dione 
(CNQX), 10 nifedipine.  Final osmolarity was adjusted to 305-315 mOsm.  Depending on 
experimental conditions, extracellular solutions would also contain either 3 µM 
thapsigargin (Tg) or 100 µM lanthanum (La3+) to evoke pannexin currents or block the 
channel respectively. 
A two-stage pipette puller (Narishige PC-10) was used to make borosilicate glass 
capillaries under heat to form the patch pipette.  The patch pipette was filled with 
intracellular solution containing (in mM): 130 K-Gluconate, 10 ethylene glycol 
tetraacetic acid (EGTA), 10 HEPES buffer, 10 KCl, 5 TEA, 4 MgATP, 2 MgCl2, and 1 
CaCl2 adjusted to pH 7.3 with KOH and osmolarity 295-305 mOsm.  The centre of the 
cell body was approached with a patch electrode of 4-6 MΩ of resistance in solution.  
Upon approaching the cell, negative pressure was applied to the patch pipette to seal onto 
the cell membrane.  The holding voltage was clamped at -60 mV to mimic the resting 
membrane potential of a neuron and negative pressure was gently increased until a 1 GΩ 
seal was achieved.  To break through the membrane, while maintaining a tight seal, 0.1 cc 
of negative pressure was gently re-applied together with a 2 kHz pulse for 0.6 ms. Upon 
break-through the inner contents of the cell are continuous with the intracellular solution 
of the patch pipette.  Recording protocol, either acute-response (section 2.4.1) or chronic-
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response (section 2.4.2), could then be initiated. Traces were recorded using Axoscope 
and Clampex softwares (Molecular Devices). 
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A)       B) 
 
 C)       D) 
 
 
Figure 2.2 Experimenter’s view of cells during patch-clamp recordings. 
A) Pyramidal hippocampal CA1 neuron viewed under phase contrast. B) Pyramidal 
neuron in whole-cell patched configuration with micropipette.  C) Pannexin-1 inducible 
HEK 293 cells, transfected with GFP tagged STIM.  D) Transfected HEK 293 cell in 
whole-cell patched configuration with micropipette. 
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2.4.1  Recording acute-response pannexin currents 
A shifting multi-barrel perfusion system was loaded with 1) control extracellular solution 
2) extracellular solution containing ER stress inducing compound 3) extracellular 
solution containing pannexin channel blocker (Fig. 2.3).  Barrels were positioned to 
achieve a flow rate of 1 mL/min.  Upon break-through of the cell membrane, control 
barrel was allowed to flow for the duration of a 2-5 minutes stable baseline recording. 
Initial break-through leak currents of less than -300 pA were considered healthy.  Flow 
was then switched to the ER stress inducing solution barrel for either a 20-minute 
duration or the development of a characteristic pannexin current.  Flow was finally 
switched to the pannexin blocker solution barrel until either baseline current was re-
established or no further decrease in current was made.  Traces were analyzed for peak 
current, residual current after block and/or total charge transfer depending on the 
objective of the experiment.  
 
 
Figure 2.3 Representation of extracellular solution application via a shifting 
barrel perfusion system in close proximity to the patched neuron 
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2.4.2  Recording chronic-response pannexin currents 
For experiments where acute application of the inducing compound was insufficient in 
evoking pannexin currents, cells were pre-treated for 24 hours to mimic chronic 
application.  Recording of chronic responses were performed on neurons 24 hours pre-
treated with 1 µM oligomers of Aβ1-42.  Barrel perfusion system was loaded with 1) 
control extracellular solution 2) extracellular solution containing pannexin channel 
blocker.  Barrels were positioned to achieve a flow rate of 1 mL/min.  Recording was 
started upon gigaseal of patch electrode to cell membrane, prior to break-through. Initial 
current at the time of break-through was recorded and maintained for 2-5 minutes before 
flow was switch from control to pannexin blocker solution until either baseline current 
was re-established or no further decrease in current was made.  Traces were analyzed for 
initial/constitutive current and percentage block of response. 
 
 
2.5  Statistical analysis 
Clampex and Clampfit (Molecular Devices) softwares were used to extract raw data.  All 
data values reported are expressed as ± standard error.  Statistical analysis was conducted 
using GraphPad Prism 5 (GraphPad Software, CA).  Unpaired t-test was used to compare 
parameters of channel activity between treatment groups.  Multiple groups were analyzed 
by ANOVA with Tukey’s post hoc test.  For all statistical tests, P<0.05 was considered 
significant. 
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2.6  Sources of drugs, reagents and peptides 
The sources of drugs, reagents and peptides used in this study are from the following 
suppliers: 
Bishop Canada KCl, HEPES, EGTA 
Enzo Life Sciences zVAD-FMK 
Invitrogen Thapsigargin, Neurobasal Culture Medium, B-27 
Pfizer Doxycycline 
Polyplus JetPRIME 
rPeptide Aβ1-42, Aβscrambled 
Sigma-Aldrich 
NaCl, K-Gluconate, D-Glucose, CaCl2, MgCl2, TTX, TEA, 4-AP, 
Nifedipine, CdCl2, Mg(ATP)2, La3+, Probenecid, Carbenoxolone, 
Dulbecco’s Modified Eagle Medium, Fetal Bovine Serum, HFIP, 
PP2, DMSO 
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Section 3 
 
RESULTS 	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3.1 ER stress induces pannexin activation 
My first set of experiments was designed to show a relationship between ER stress and 
pannexin channel activity. Upon successful patching of a healthy candidate cell 
(described in section 2.4), recording started with 2-3 minutes of exposure with control 
solution to establish a stable baseline.  Thapsigargin, an ER stress inducer by SERCA 
pump inhibition, at 3 µM in extracellular fluid (ECF) was applied via barrel perfusion 
system to the patched neuron.  In neurons, inward currents indicative of pannexin channel 
activation developed 10-15 minutes into thapsigargin application.  The rate of ECF 
perfusion was 1 mL/min in all experiments.  The evoked inward currents were rapidly 
blocked by perfusion of 100 µM lanthanum, a reversible blocker of pannexin channels.  
Reversibility of lanthanum is exhibited by the onset of a large inward current upon 
washout of lanthanum with control ECF perfusion. Under these conditions, pannexin 
currents were recovered within seconds (Fig. 3.1A).  Thapsigargin evoked pannexin 
currents were highly reproducible and the sensitivity to lanthanum blockade could be 
repeated so long as blocker was applied while the cell remained healthy/responsive. 
Indeed, if the sustained large inward pannexin current were continued for a longer 
duration, the health of the cells would deteriorate at which time lanthanum could no 
longer block the much larger currents observed. Therefore, lanthanum ECF was generally 
applied when developing inward currents either plateaued or reached -2500 to -3000 pA.   
 
In neurons, pannexin currents, identified by their pharmacological sensitivity, were 
evoked upon treatment with 3 µM thapsigargin ECF (-3010 ± 641 pA, n=4), whereas 
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pannexin currents did not develop under control ECF (-122 ± 29 pA, n=4) (P=0.0041) 
(Fig. 3.1C).  This serves as a demonstration of ER stress induced pannexin activation. 
 
These results are consistent with recent findings from the Jackson/MacDonald lab 
illustrating pannexin activation in response to various ER stress inducers, namely 
thapsigargin and cyclopiazonic acid, both SERCA inhibitors, as well as tunicamycin, an 
inhibitor of N-glycosylation (Appendix A Fig. S1A).  Characterization of pannexin 
current was previously done in the Jackson/MacDonald lab using a combinatorial 
approach to rule-in and rule-out candidate non-selective cation channels.  Current 
sensitivity to known pannexin blockers lanthanum, carbenoxolone, probenecid and 10panx 
peptide ruled-in pannexin channels.  Insensitivity to SKF96365 (ORAI/TRPC channel 
blocker) and Ca2+-free solution (inhibits TRPM/connexin channel activation) further 
demonstrated the current to be pannexin mediated (Appendix A S1B). 
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Pharmacological ER stress induced pannexin 
activation in CA1 hippocampal neurons
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Figure 3.1.  Pharmacological ER stress inducers evoke pannexin activation in 
hippocampal CA1 neurons. 
A) Representative trace of whole-cell patch clamp recording from hippocampal CA1 
pyramidal neuron. Inward current develops in response to acute treatment of extracellular 
solution containing 3 µM thapsgargin (Tg).  Current is reversibly blocked by 100 µM 
lanthanum (La3+) solution.  Horizontal bars indicate drug application periods. Voltage 
was clamped at a holding potential of -60 mV.  B) Summary bar graph showing averaged 
peak currents (pA) under application of control ECF, 3 µM thapsigargin containing ECF 
and 100 µM lanthanum containing ECF in neurons (n=4). C) IV curve, taken at the peaks 
of currents recorded under Tg were linear, over the voltage range -50 to 100 mV, and 
reversed at 0 mV, consistent with the IV characteristics of pannexin currents. Values are 
represented as mean ± SEM.  Statistical analysis: unpaired Student’s t-test, P < 0.05. 
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3.2 Aβ42 induced pannexin activation in neurons 
Given previous findings that ER stress is associated with various neurodegenerative 
diseases, I explored the possibility that Aβ42 treatment of neurons, known to trigger ER 
stress (Chefekar et al., 2007), could promote pannexin channel activation.  I conducted 
this experiment in hippocampal CA1 pyramidal neurons, knowing that the hippocampus 
is important for learning and memory and especially vulnerable to injury in Alzheimer’s 
Disease patients (Troncoso et al., 1996).  I first examined the effects of acute Aβ42 
application during recordings from cultured CA1 neurons.  No current was evoked during 
60 minutes of constant perfusion of 1 µM Aβ42 in ECF (Fig. 3.2A).  This negative finding 
was not unexpected since Aβ42 is not thought to target the ER directly, unlike 
thapsigargin for instance, and therefore likely requires a more chronic treatment with 
Aβ42.  The consequence of chronic Aβ42 treatment was therefore examined next in 
neurons pre-treated with 1 µM Aβ42 for 24 hours. Recording began immediately after 
forming a seal onto the cell membrane with a resistance greater than 1 gigaohm, but 
before breaking through the membrane (Fig. 3.2B).  24 hour pre-treatment with Aβ42 
resulted in large inward current, consistent with known pannexin pharmacology.  
Pannexin currents were not observed in vehicle and scrambled Aβ42 peptide groups 
(P<0.05) (Fig. 3.2C).  These pannexin currents were seen immediately upon 
breakthrough of the cell membrane, as opposed to developing over minutes as previously 
seen under thapsigargin treatment, indicative of constitutive pannexin activation in 
response to chronic (24 hour) Aβ42 treatment. 
Control experiments were done using vehicle (0.1% DMSO) treatment and a scrambled 
Aβ peptide.  This ensured that the result was an effect of Aβ42, rather than a non-specific 
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effect of applying a peptide extracellularly.  These characteristic pannexin currents were 
not observed in recordings from either control group (Fig. 3.2C). 
To confirm the oligomerization of Aβ42, the Jackson/MacDonald lab has tested the final 
product by western blot (Appendix A Fig. S2). 
  
	   	   35
  
	  
Effect of 24 hour pre-treatment of 1 uM Aβ42 
oligomers on pannexin current in neurons
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Figure 3.2. Effect of 24 hour extracellular pre-treatment of 1 µM Aβ42 oligomers 
on pannexin currents in whole-cell voltage-clamp recordings from hippocampal 
CA1 pyramidal neurons. 
A) Lack of current in a recording of acute treatment of 1 µM Aβ42.  B) Representative 
trace of pannexin current from a neuron 24 hours pre-treated with 1 µM Aβ42. C) In the 
group treated with 1 µM Aβ42 oligomers, constitutive pannexin currents were observed at 
the point of gaining whole-cell access.  These constitutive currents were lanthanum 
sensitive in the Aβ42 group and significantly larger than control groups.  Pre-treatment 
with vehicle (0.1% DMSO) as well as scrambled versions of the Aβ42 peptide did not 
produce pannexin currents. Voltage was clamped at holding potential -60 mV.  Values 
are represented as mean ± SEM.  Statistical analysis: one-way repeated-measures 
ANOVA with Tukey’s post-hoc test.  Identical letters (a, b) indicate no significant 
difference between groups (P < 0.05). 
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3.3 ER stress induced pannexin-1 activity is modulated by STIM proteins 
To identify a molecular mediator in the pathway coupling ER stress to pannexin 
activation, I investigated the role of the ER stress sensor, STIM, in modulating pannexin 
currents. I used a mammalian recombinant expression system allowing me to overexpress 
the proteins of interest, pannexin-1 and STIM.  The experimental design was as follows; 
recordings were performed from HEK 293 cells transiently transfected with pannexin-1 
alone (absence of STIM) along with full-length STIM or a mutated variant of STIM.  The 
mutated STIM (STIM1ΔERM) possessed a domain deletion such that the ERM domain, 
which has been shown as the critical domain in ER stress induced ORAI channel 
activation, was deleted as illustrated in Fig. 2.1 of methods section. 
From whole-cell voltage-clamp recordings, application of 3 µM thapsigargin to HEK 
cells expressing full-length STIM1 evoked a characteristic pannexin current.  Consistent 
with the known pharmacological sensitivity of pannexin channels and evoked large 
inward currents during 3 µM thapsigargin application (-2383 ± 329 pA, n=3).  In the 
absence of thapsigargin, under the perfusion of control ECF, comparable currents were 
not observed (-73 ± 49 pA, n=3) (P=0.0023) (Fig. 3.3B).  In contrast, large currents in 
response to thapsigargin were not observed in the absence of STIM.  This is consistent 
with previous unpublished results from the Jackson/MacDonald lab where thapsigargin 
did not evoke large pannexin currents in HEK cells that were transfected with pannexin-1 
only. Large pannexin currents could only be recorded when co-transfecting either STIM1 
or STIM2 along with pannexin-1 (Appendix A Fig. S3).  This suggests STIM is required 
for pannexin activation in response to thapsigargin.  
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Next, I examined the effects of 3 µM thapsigargin application to HEK cells expressing a 
mutated variant of STIM, STIM1ΔERM.  In contrast to cells expressing full length 
STIM1, thapsigargin did not evoke pannexin currents in cells expressing the truncated 
STIM variant (-585 ± 329 pA, n=6) (P=0.12) (Fig. 3.3C). In summary, when comparing 
the peak currents evoked by thapsigargin between STIM1 and STIM1ΔERM groups, the 
current is significantly larger in the STIM1 group (p=0.0113) (Fig. 3.3D). 
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ER stress induced panx1 activation in 
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Effect of ERM domian deletion on STIM1 
modulation of ER stress induced panx1 current
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Figure 3.3.  Effect of ERM-domain deletion from full-length STIM on ER stress 
induced pannexin-1 currents in whole-cell voltage-clamp recordings from HEK 293 
cells transiently transfected with pannexin-1 and either full-length or mutated 
STIM1.  A) Representative traces of whole-cell patch clamp recordings from transiently 
transfected HEK 293 cells overexpressing pannexin-1 and either full length STIM1, 
mutated STIM1 with deletion of the ERM domain or empty vector ie. no expression of 
STIM1. Horizontal bars indicate drug application periods.  Summary bar graph showing 
peak current (pA) under application of control ECF, 3 µM thapsigargin-containing ECF 
and 100 µM lanthanum-containing ECF with overexpression of B) full length STIM1 
(n=3) and C) mutated STIM1 (n=6). D) Comparison of peak current between full length 
STIM1 and mutated STIM1 during thapsigargin treatment.  Voltage was clamped at 
holding potential -60 mV.  Values are presented as mean ± SEM.  Statistical analysis: 
unpaired Student’s t-test, P < 0.05. 
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3.4 ER stress evoked pannexin current is not STIM-dependent in neurons 
After observing ER stress induced pannexin activation in both neurons and HEK cells, 
followed by evidence of this response being STIM-dependent in HEK cells, the next step 
was to determine if pannexin activation in neurons also required STIM.  This would 
establish a mechanism for coupling ER stress to pannexin activation in neurons and 
provide a candidate mechanism for the aforementioned Aβ42 induced pannexin activation. 
To investigate STIM-dependent pannexin activation in neurons, I recorded ER stress 
induced pannexin currents from hippocampal CA1 pyramidal neurons where expression 
of STIM1 and STIM2 was knocked down after 14-16 days of lentiviral transduction with 
shRNA sequences targeting STIM1 and STIM2.  Fluorescent tags, GFP for STIM1 and 
mCherry for STIM2, were expressed on the same vector as the shRNA sequences.  This 
allowed for visual identification and selection of infected neurons for whole-cell 
recordings. 
To evaluate the effectiveness of the shRNA in knocking down expression of the proteins 
of interest, the Jackson/MacDonald lab performed western blots assaying for levels of 
STIM1 and STIM2 using whole-cell protein extracts 14-16 days post-infection with 
shRNA.  Levels of STIM1 and STIM2 were quantified densitometrically and normalized 
to β-actin.  Results show that the expression of STIM1 and STIM2 was effectively 
knocked down by 70-90% from control levels by their respective shRNA target 
sequences (Appendix A S4). 
When comparing peak currents, evoked by 3 µM thapsigargin, between the STIM 
knockdown group (-1685 ± 292 pA, n=5) and the control group (-2016 ± 200 pA, n=6), 
no significant difference was observed (P=0.3620) (Fig. 3.4A).  In the same recordings, 
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residual current remaining after 100 µM lanthanum was also analyzed.  STIM 
knockdown group (-487 ± 192 pA, n=5) and control group (-560 ± 167 pA, n=6) showed 
no significant difference (P=0.7749) (Fig. 3.4C).  Another parameter analyzed was total 
charge transferred across the membrane, for the duration of the thapsigargin application, 
as measured by the area under the curve (i.e. time integral of membrane current).  No 
significant difference was observed between STIM knockdown (-216 ± 46 pA, n=5) and 
control group (-237 ± 82 pA, n=6) for total charge transfer (P=0.8336) (Fig. 3.4E).  Since 
it is not certain that the knockdown of STIM expression was 100% effective, I needed to 
address the possibility that 3 µM thapsigargin may be sufficient to evoke an ER stress 
response mediated by the residual STIM protein, post-knockdown. Therefore, these 
recordings were repeated with 1 µM thapsigargin application instead of 3 µM. However, 
large inward currents were nevertheless observed in response to this lower concentration 
of Tg.  
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Figure 3.4. Effect of knockdown of STIM1 & 2, via RNAi, on ER stress pannexin 
currents in whole-cell patch-clamp recordings from hippocampal CA1 pyramidal 
neurons. 
A) Peak pannexin current was not altered in response to 3 µM thapsigargin B) nor in 
response to 1 µM thapsigargin.  C) Residual pannexin current after blockade with 100 
µM lanthanum was not altered in response to 3 µM thapsigargin D) nor in response to 1 
µM thapsigargin.  E) Total charge transfer, as determined by area under curve of current 
amplitude over time recording, was not altered in response to 3 µM thapsigargin F) nor in 
response to 1 µM thapsigargin.  Voltage was clamped at holding potential -60 mV.  
Values are represented as mean ± SEM (STIM1&2 KD, n=5; scrambled, n=6).  .  
Statistical analysis: unpaired Student’s t-test, P < 0.05. 
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3.5 ER stress evoked pannexin current is not Src-kinase dependent in neurons  
My findings suggest that STIM is not required to facilitate ER stress induced pannexin 
channel activation in cultured neurons. I therefore examined alternative candidate 
mechanisms for promoting pannexin activation in neurons.  In light of recently published 
findings in which Src-family kinases were shown to mediate neuronal pannexin channel 
activation induced by hypoxia (Weilinger et al., 2012), I decided to investigate the role of 
Src-family kinases in ER stress induced pannexin activation.  In the study from the 
Thompson lab, inhibition of Src-family kinases was found to reduce pannexin current 
size and cumulative charge transferred across the membrane during pannexin activation. 
My experiment was designed to assess the requirement of Src by examining whether the 
specific inhibition of Src can prevent the activation of pannexin channels in response to 
ER stress inducer thapsigargin. To inhibit Src-family kinases, I used the drug PP2 at a 
concentration of 10 µM in ECF, which was the effective concentration used by the 
Thompson lab. 
Unlike the results of the Thompson lab, my recordings do not show a reduction in peak 
thapsigargin-evoked pannexin currents between Src-inhibitor treated (-1883 ± 188 pA, 
n=6) and control recordings (-2352 ± 225 pA, n=5) (P=0.1399) (Fig. 3.5A).  When 
comparing residual current remaining after 100 µM lanthanum was applied, again there is 
no difference between neurons treated with 10 µM PP2 (-986 ± 117 pA, n=6) and control 
recordings (-823 ± 185 pA, n=5) (P=0.4588) (Fig. 3.5B).  Finally, comparison of total 
charge transfer, measured by area under the curve in these same recordings, was also the 
same between 10 µM PP2 treated (-149 ± 112 pA, n=6) and control groups (-237 ± 60 
pA, n=5) (P=0.5383) (Fig. 3.5C).  The results of this experiment suggest the coupling of 
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ER stress to pannexin channel activation in neurons is independent of phosphorylation by 
Src-family kinases. 
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Figure 3.5. Effect of Src-family kinase inhibition on ER stress induced pannexin 
currents in whole-cell patch-clamp recordings from hippocampal CA1 pyramidal 
neurons. 
Recordings were performed in the presence of Src-family kinase inhibitor PP2 at 10 µM 
in ECF.  A) Peak pannexin current during 3 µM thapsigargin application was not altered 
between Src-inhibtor and control groups.  B) Residual pannexin current after blockade 
with 100 µM lanthanum application was not altered between Src-inhibitor and control 
groups.  C) Total charge transfer, as determined by area under curve of current amplitude 
over time recording, was not altered between Src-inhibtor and control groups. Voltage 
was clamped at holding potential -60 mV.  Values are represented as mean ± SEM (10 
µM PP2, n=6; control, n=5).  Statistical analysis: unpaired Student’s t-test, P < 0.05.  
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3.6 ER stress evoked pannexin current is not caspase-dependent in neurons 
After ruling out STIM and Src-family kinases as mediators of ER stress induced pannexin 
activation in neurons, I examined whether yet another candidate mechanism was 
responsible, namely caspase-mediated cleavage of the pannexin channel.  Indeed, a 
previously identified pathway in pannexin activation during apoptosis by the 
Ravichandran lab suggested that cleavage of the intracellular C-terminus of pannexin 
channels by caspase 3 or caspase 7 was necessary to open the channel pore during 
pannexin activation (Chekeni, 2010).  Their use of intracellular 20 µM zVAD-FMK, a 
commercially available caspase inhibitor, was effective in preventing pannexin current 
from developing under apoptosis inducing conditions in jurkat cells expressing pannexin-
1 channels.  My experiment was designed to observe the effects of inhibiting caspase 3 
and caspase 7 in whole-cell recordings of ER stress induced pannexin currents in 
neurons. To inhibit caspases 3 and 7, I used the same compound zVAD-FMK at a 
concentration of 20 µM in my intracellular fluid (ICF) solution, which was the effective 
concentration used by the Ravichandran lab. 
In these recordings, application of 3 µM thapsigargin reliably evoked pannexin currents 
as seen in control neurons.  Current size and sensitivity were identical to control 
recordings.  Additional recordings in neurons confirmed that 20 µM zVAD-FMK was 
ineffective in preventing pannexin activation in response to thapsigargin.  This suggests 
that caspase cleavage is not required for ER stress induced pannexin activation.   
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Figure 3.6. Effect of caspase inhibition on ER stress induced pannexin currents in 
whole-cell patch-clamp recordings from hippocampal CA1 pyramidal neurons. 
Both recordings were performed in the presence of caspase inhibitor, zVAD-FMK at 20 
µM in ICF.  Traces of recordings from preliminary trials demonstrating pannexin current 
was not altered by caspase inhibitor in response to 3 µM thapsigargin.  Pannexin currents 
were identified by sensitivity to pharmacological pannexin blockers.  Pannexin current 
block by application of 100 µM lanthanum was not altered by the presence of 
intracellular caspase inhibitor. Voltage was clamped at holding potential -60 mV. 
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Section 4 
 
DISCUSSION 
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4.1 Summary of key findings 
In this project, I investigated potential mechanisms underlying pannexin channel 
activation in response to ER stress.  Specifically, I explored the involvement of STIM 
proteins in mediating this response and aimed to identify a critical domain that was 
required to facilitate an interaction.  I confirmed previous unpublished results from our 
lab wherein ER stress inducers activated pannexin currents in neurons, in accordance 
with the pharmacological profile of pannexin-1 channels.  I then identified this activation 
to be contingent on the recruitment of STIM in the HEK cell expression system. 
Furthermore, I identified the ERM domain of STIM as a critical domain in activating 
pannexin as suggested by the lack of pannexin current when overexpressing STIM 
molecules with deleted ERM domains in HEK cells.  In neurons, however, knockdown of 
STIM proteins was not sufficient in abolishing ER stress induced pannexin currents as 
noted by amplitude peak current, residual current as well as total charge transfer.  Upon 
exploring alternative mediators of ER stress induced pannexin activation, comparable 
pannexin currents were evoked independent of Src-family kinases and cleavage by 
caspases.  To summarize the key results, pannexin activation in response to ER stress has 
been established, however, a molecular mechanism underlying this activation has been 
demonstrated in HEK cells but not yet in neurons. 
  
 
4.2 Pannexin channel activation in response to ER stress 
Using whole-cell voltage-clamp recordings of pannexin currents from cultured pyramidal 
CA1 neurons of mouse hippocampus, ER stress was induced by acute treatment with 
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commonly used ER stressors. Our lab has used 3 different inducers of ER stress, namely, 
SERCA pump inhibitors thapsigargin and cyclopiazonic acid as well as N-glycosylation 
inhibitor tunicamycin.  Each of these agents has been shown to reliably induce ER stress 
in a number of different systems (Tobmal et al., 2000; Lehrman, 2001; Pirot et al., 2006).  
These agents all act upon the ER and are thought to provoke the accumulation of 
misfolded proteins in the ER.  This occurs either as a consequence of disrupting ER Ca2+ 
homeostasis (thapsigargin and cyclopiazonic acid) or by interfering with glycosylation 
(tunicamycin), both of which are necessary for regulated protein folding in the ER.  The 
consequent accumulation of unprocessed proteins, brought on by the disruption in Ca2+ 
homeostasis and misfolding of proteins within the ER, initiates ER stress (Michalek et al., 
2002).  These three pharmacological ER stress inducers have been shown by our lab to 
reliably produce pannexin channel activation (Appendix A S1A).  In a first series of 
experiments, I have confirmed the activation of pannexin channels by the ER stressor, 
thapsigargin.  I was able to reproduce this result in cultured pyramidal neurons from the 
CA1 region of mouse hippocampus.  Acute extracellular application of 3 µM thapsigargin 
while recording from whole-cell patch-clamped cells, consistently evoked a 2000-3000 
pA current that could be reversibly blocked with the application of 100 µM lanthanum 
(Figure 3.1).  
 
Stemming from the lack of a specific blocker for pannexin channels, a common criticism 
towards pannexin channel identification is in the certainty that the recorded current is in 
fact pannexin.  Accordingly, our lab has extended this result over the known 
pharmacological profile of pannexin channels to positively identify the currents generated 
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as being pannexin mediated.  Thus, we have shown these currents to be sensitive to 
lanthanum, carbenoxolone, probenecid, 10panx peptide, as well as insensitive to the ORAI 
and TRPC channel blocking compound, SKF96365; and also the connexin and TRPM 
blocking condition, calcium-free extracellular recording solution.  The resulting 
pharmacological profile uniquely identifies pannexins channels as being responsible for 
ER stress activated currents. 
 
 
4.3 ER stress-pannexin coupling modelled in neurodegenerative disease 
Although pharmacological inducers provide a reliable experimental means of modeling 
ER stress, the next step was to demonstrate the relevance of ER stress induced pannexin 
activation in neurological disease. My objective was to extend these findings by 
determining whether pannexin activation is observed in neurological disease where ER 
stress is known to occur.  ER stress has been demonstrated in response to exposure of 
cultured neurons to Aβ42.  In terms of the molecular players involved, the three branches 
of the UPR start with activating-transcription-factor-6 (ATF6), protein-kinase-RNA-like-
ER-kinase (PERK), and inositol-requiring-enzyme-1 (IRE1).  In the absence of ER stress, 
BiP, also an ER resident protein, remains bound to PERK, IRE1, and ATF6, suppressing 
their signaling activity.  However, when the protein folding capacity of the ER is 
exhausted and umisfolded proteins accumulate, BiP dissociates from its binding partners 
and binds to misfolded proteins, initiating the UPR (Schroder and Kaufman, 2005).  
These three active constituents (ATF6, PERK, IRE1) and BiP are typically screened for 
as markers of ER stress. 
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Previous studies have shown increases in UPR markers such as PERK, IRE1, ATF6 and 
BiP in response to Aβ42 application (Katayama et al., 2003; Ferreiro et al., 2006; Seyb et 
al., 2006).  The aforementioned findings of my earlier experiments showing ER stress 
coupled pannexin activation provided a rationale for me to investigate whether ER stress 
by Aβ42 can promote pannexin channel activation.  In these experiments, I showed 
constitutive activation of pannexin channels in response to 24 hours of pre-treatment with 
Aβ42.  Currents recorded upon initial breakthrough during whole-cell voltage-clamp 
recordings were significantly larger than those in the vehicle treated group (Figure 3.2C).  
Recorded currents were identified as pannexin currents based on their sensitivity to 100 
µM lanthanum blockade as well as their lack of sensitivity to other channel blockers 
contained in recording solutions (TEA, TTX, CNQX, bicuculline, 4-AP, nifedipine).  
This finding is the first to demonstrate pannexin channels activation in a model of 
Alzheimer’s Disease.   
 
Thus far, I have not defined a role for pannexin channels in the context of 
neurodegeneration. Given the previous implications of pannexin channels mediating cell 
death and inflammation, it is conceivable that pannexin channels could be functioning in 
a similar role in Alzheimer’s Disease.  Whether or not pannexin channels contribute to 
Aβ42 induced neurotoxicity remains to determined. Therefore, a follow-up experiment to 
this study would be to examine if the absence of pannexin channels, either by knockdown 
or knockout, reduces neuronal cell death in this model. This can be assessed using either 
an MTT assay to measure cell viability based on metabolic activity, or using live/dead 
staining to assay for membrane integrity. 
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4.4 Molecular basis for pannexin activation during ER stress 
The primary objective of my study was to establish the mechanisms through which ER 
stress provokes pannexin activation.  I hypothesized that pannexin channel activation 
during ER stress is contingent on recruitment of STIM proteins.  My electrophysiological 
data in transfected HEK 293 cells was strongly in favour of my hypothesis.  Only cells 
transfected with full length STIM and inducibly expressed pannexin-1 had ER stress 
evoked currents that were pharmacologically identified as pannexin currents (Fig. 3.2).  
In contrast, the cells transfected with an empty vector or just GFP, for visual confirmation 
of transfection efficiency, were not able to generate a pannexin current in response to 
pharmacological ER stress induction.  This group portrayed the absence of STIM and 
made it evident that ER stress induced pannexin activation was contingent on the 
recruitment of STIM.  In these experiments, it was expected that depletion of ER Ca2+ 
allowed Ca2+ to dissociate from the intraluminal N-terminal E-F binding hands of STIM, 
normally maintained as homodimers at rest when the ER is replenished.  The dissociation 
of Ca2+ provokes a conformational change that releases the auto-inhibitory domain of 
STIM from binding to itself. This activates STIM proteins and allows them to 
oligomerize and translocate as a cluster to regions of the ER that are in close proximity to 
the plasma membrane. Within these ER-plasma membrane junctions we propose that 
STIM proteins physically interact with plasma membrane bound pannexin channels to 
promote their activation. Precedence for the interaction of STIM with plasma membrane 
channels has been established in the context of ORAI activation during store-operated 
Ca2+ entry, as modeled in Figure 4.1. 
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Figure 4.1 Schematic model of STIM-ORAI interaction during store-operated 
Ca2+ entry 
Upon ER-Ca2+ store depletion, STIM oligomerizes and translocates towards ER-PM 
junctions where it interacts with and activates Ca2+ permeable ORAI channels to 
replenish ER-Ca2+ stores. (Modified from Roos et al., 2005) 
 
In this context, recent evidence suggested STIM proteins not only participate in store-
operated Ca2+ entry to regulate ER Ca2+ refilling but may also function more broadly as a 
sensor for ER stress (Soboloff et al., 2011).  Independent of ER Ca2+ depletion, STIM 
activated by reactive oxygen species (ROS) couples to ORAI channels suggesting STIM 
also functions as a sensor of oxidative stress (Hawkins et al., 2010).  Additionally, 
cellular stress from transient temperature variation can also induce STIM-ORAI coupling 
independent of ER Ca2+ depletion (Xiao et al., 2011). Upon further review of the 
literature describing ORAI channel activation during store-operated Ca2+ entry, it has 
been reported that the Ca2+-channel activating domain (CAD) region of STIM1, residues 
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342-348, is sufficient to constitutively activate ORAI channels (Park et al., 2009).  In its 
resting conformation, the CAD region of STIM1 is auto-inhibited by intramolecular 
electrostatic interactions.  Activation of STIM triggers conformational changes exposing 
the acidic residues of the CAD region to interact with the basic sequences on ORAI 
(Wang et al., 2010). This information led me to investigate whether the CAD region of 
STIM was crucial in activating pannexin channels during ER stress, analogous to its role 
in activating ORAI channels during store-operated Ca2+ entry.  Experimentally, I needed 
a system where mutated STIM proteins, with deleted CAD regions, could be expressed. 
Therefore, instead of recording in cultured neurons where I could not readily control 
STIM expression levels, I again used HEK cells expressing pannexin-1 (doxycycline-
inducible) where I could transiently transfect DNA encoding for mutated STIM proteins.  
First, I demonstrated that in the absence of transient expression of STIM, thapsigargin-
evoked pannexin-1 currents are absent in these cells (Figure 3.3A), a result I reproduced 
from previous Jackson/MacDonald lab data (Appendix A S3).  One control experiment 
that remains to be completed is the recording of ER stress induced current in HEK cells 
expressing STIM but not expressing pannexin-1, an experiment where we do not expect 
current to be evoked. 
 
To advance that finding, I recorded panx1 currents in response to 3 µM thapsigargin in 
HEK cells expressing pannexin-1 (induced with doxycycline) with transient transfection 
of mutated STIM1 whereby the ERM domain of STIM1, which contains the CAD region, 
was deleted from the full-length protein (STIM1ΔERM).  The lack of current that 
developed in the STIM1ΔERM group compared to the full length STIM group provided 
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evidence that the ERM domain is a critical domain in mediating the coupling of ER stress 
to pannexin activation (Figure 3.3D).  This experiment reinforces the notion that a 
physical interaction may exist between active oligomeric STIM complexes and pannexin 
channels on the plasma membrane, analogous to the well-established interaction between 
active oligomeric STIM complexes and ORAI channels on the plasma membrane.  
Whether such an interaction between STIM and pannexin is direct or indirect, via a 
macromolecular complex, is yet to be determined and provides a rationale for future co-
immunoprecipitation experiments on STIM-pannexin as well as CAD-pannexin in a 
model of ER stress. 
 
 
4.5 Contribution of STIM proteins to pannexin channel activation in neurons 
After demonstrating ER stress induced pannexin activation pharmacologically and also 
with Aβ42, I sought to identify the underlying mechanisms which couple ER stress to 
pannexin activation in neurons.  My own results suggest that STIM, and more specifically 
its ERM domain, is required for pannexin activation in HEK cells in response to 
treatment with ER stressors.  This led me to predict that a knock down of STIM proteins 
in neurons would abolish ER stress induced pannexin currents.  To test this idea, I 
recorded in neurons which had been lentiviral infected with DNA encoding for short 
RNA hairpins targeting STIM transcripts (shRNASTIM1 and shRNASTIM2) to knockdown 
expression of STIM proteins. Separate biochemical experiments from sister cultures 
infected in parallel confirmed the reduction of STIM expression (Appendix A S4).  
Opposing the prediction, thapsigargin-induced pannexin currents were evoked in STIM 
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knockdown neurons with no difference observed in peak current, residual current after 
100 µM lanthanum block or total charge transferred across the plasma membrane 
between the knockdown and the scrambled shRNA groups (Figure 3.4 A, C, E).  It was 
conceivable that 3 µM thapsigargin was a high enough concentration to evoke an ER 
stress response mediated by only the residual STIM (10-30% of control levels) left 
behind after shRNA knockdown.  For this reason, I repeated the experiment using a lower 
dose, 1 µM thapsigargin.  However, pannexin currents of similar size and progression 
were evoked under the low dose as well, indicating the response was not dose-dependent 
at thapsigargin concentrations greater than 1 µM (Figure 3.4 B, D, F). 
 
When interpreting the functional consequence of this result, at face value the result of my 
STIM-KD experiment in neurons (Figure 3.4) suggests that natively expressed STIM 
does not contribute to pannexin channels activation in response to Thapsigargin treatment 
of cultured hippocampal neurons.  One pitfall of the approach utilized is that recordings 
may have been made from neurons in which less than complete knockdown of STIM has 
been achieved.  To maximize the likelihood of recording only from certain successfully 
infected neurons, each lenti-transfer vector, used to express shRNA sequences, also 
allowed expression of different fluorescent marker (GFP and RFP).  shRNASTIM1 was co-
expressed with GFP and  shRNASTIM2 was co-expressed with mCherry.  By selecting 
only neurons that were GFP-positive as well as mCherry-positive, I could confirm that 
the neurons I recorded from did express both shRNA variants.  Using this criteria I 
observed an infection efficiency of 90-100% in cultured neurons.  Our western blot data 
suggests substantial reduction (~70-90%) in STIM1&2 after lentiviral shRNA infection, 
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however, detection in western blotting is not as sensitive as electrophysiological 
recordings, nor does it show any functional consequence.  Though in reduced amounts, 
STIM may have still been expressed enough to observe functionality in whole-cell 
recordings.  Therefore, it is possible that the level of reduction by our shRNASTIM1/2 was 
not sufficient in abolishing STIM function. 
 
This result could be influenced by many factors including the limited effectiveness of 
shRNA in achieving complete knockdown and/or the overexpression of visual fluorescent 
markers increasing cellular stress and promoting pannexin activation as part of an 
inflammatory response.  Although several interpretations to this negative result can be 
inferred, ultimately, this finding led me to consider alternative candidate mechanism 
underlying ER stress induced pannexin activation. 
 
 
4.6 Exploring alternative mechanisms of pannexin activation in neurons 
A recent study demonstrating anoxia-induced pannexin currents employed Src-family 
kinase inhibitor PP2 to prevent pannexin currents by blocking tyrosine phosphorylation at 
the pannexin c-terminus mediated by NMDA-receptor activation (Weilinger et al., 2012). 
In this study done by the Thompson lab, upon anoxia-induced pannexin activation, initial 
depolarization, residual current after block and cumulative charge transfer were analyzed.  
Residual current after block, which represents non-pannexin mediated activity, and 
cumulative charge transferred were significantly reduced in PP2-treated groups compared 
to vehicle treated.  This study was performed in a model of anoxia, a well-known model 
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for generating ER stress (Bodalia et al., 2012), thus providing rationale for consideration 
as a candidate mechanism underlying the ER stress-induced model of pannexin activation 
I have presented. Furthermore, recent evidence demonstrating the activation of Src-
family kinases in response to ER stress (Yu and Kim, 2010) has made Src a candidate to 
be investigated as a mediator of ER stress induced pannexin activation. 
 
In this experiment, pannexin currents were recorded in response to 3 µM thapsigargin in 
the presence of 10 µM PP2, an inhibitor of Src-family kinases, applied extracellularly 
through the bath solution.  These recordings were from isolated pyramidal neurons of the 
mouse CA1 hippocampus region.  The results show that ER stress-induced pannexin 
currents were still evoked in the presence of a Src-family kinase inhibitor.  In accordance 
with the results from the Thompson lab, the same parameters were quantified and 
analyzed.  However, there was no difference found in the peak current amplitude, 
residual current after block with 10 µM lanthanum or total charge transferred across the 
membrane between Src-kinase inhibitor and vehicle treated groups (Fig. 3.5).  This result 
has yet to be supported in our lab with data from phosphorylation assays to determine the 
effectiveness of extracellular 10 µM PP2 in inhibiting tyrosine phosphorylation under ER 
stress.  This discrepancy in outcomes suggests that the underlying mechanism of 
pannexin activation is likely to be modality specific.  Although the literature suggests an 
overlap in activation pathways, I have demonstrated that ER stress-induced pannexin 
activation and anoxia-induced pannexin activation are not dependent on the same 
signaling molecules. 
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A recent study by the Ravichandran lab, published in 2010, identified yet another 
potential mechanisms provoking pannexin channel activation.  They showed that 
pannexin-1 is a target for caspase 3 and 7. They identified a specific caspase-cleavage site 
at the C-terminus of pannexin-1. Cleavage at this site was essential for pannexin 
activation during apoptosis.  A truncated variant of pannexin-1, truncated at its caspase-
cleavage site at the C-terminus, resulted in constitutive activation whereas 
pharmacological inhibition of caspases 3 and 7 inhibited activation of wild type 
pannexin-1 (Chekeni et al., 2010).  The findings of this study provided me with an 
alternative candidate mechanism for pannexin activation.  Given that ER stress has 
previously been shown to lead to caspase activation (Nakagawa et al., 2000), I reasoned 
that activation of caspases and their subsequent cleavage of pannexin c-terminal may 
provide a mechanism for pannexin activation.  For this experiment, I recorded pannexin 
currents in response to 3 µM thapsigargin in the presence of 20 µM zVAD-fmk, an 
inhibitor of caspases 3 and 7, applied intracellularly through the patch electrode, as 
performed by the Ravichandran lab.  I recorded from isolated pyramidal neurons of the 
mouse CA1 hippocampus region.  My preliminary observations convincingly show ER 
stress induced pannexin activation even in the presence of caspase inhibitor (Fig. 3.6).  
Although more replicates need to be done before reporting a conclusive result, it appears 
caspase-cleavage does not contribute to pannexin channel activation under the modality 
of ER stress.  This result has yet to be supported in our lab with data from experiments 
testing caspase activity to determine the effectiveness of intracellular 20 µM zVAD-FMK 
in inhibiting caspase activity during ER stress. 
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This finding did however reinstate the view that pannexin activation has modality 
specific mechanisms. This view is supported by the divergence between ER stress-
induced and apoptosis-induced pannexin activation in addition to the previously 
described divergence from anoxia-induced pannexin activation. 
 
4.7 Experiments for future studies 
I hypothesized that pannexin channel activation during ER stress is contingent on 
recruitment of STIM proteins.  This was primarily supported by results in HEK 293 cells 
where expression of STIM is necessary to reconstitute pannexin channel activation in 
response to thapsigargin application.  In this model system, my results using a STIM 
deletion construct suggests that the ERM domain of STIM, which includes the CAD 
activating domain necessary for STIM-coupling to ORAI channels, is also necessary for 
pannexin channel activation by ER stress.  Given this finding and considering the 
relatively large size (286 amino acids) of the ERM domain, a follow-up experiment 
would be to delete only the CAD domain (STIM1ΔCAD), rather than the entire ERM 
domain, to prove that CAD alone is the region interacting with pannexin channel and that 
this interaction does not involve other components of the ERM.   
 
If the result is positive (ie. Panx1 current is abolished in STIM1ΔCAD transfected HEK 
cells), the next objective would be to determine whether the CAD domain of STIM1 is 
sufficient to activate pannexin-1 by transfecting only the CAD domain fragment (rather 
than full-length STIM1 with a deleted CAD domain) into HEK 293 cells and recording 
for constitutively active panx1 currents.  A positive result in this experiment (ie. ERM 
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fragment is sufficient to activate panx1 channels), would provide further support for my 
hypothesis in the context of HEK cells where ER stress induced pannexin activation is 
mediated by STIM.  Additionally, this positive result would show that pannexin 
activation is not only achieved using pharmacological ER stress inducers but also by the 
constitutively active form of an ER stress sensing protein.  Since ERM and CAD 
fragments would no longer be attached to the intraluminal calcium binding E-F hands of 
STIM, these fragments would be useful tools in modeling constitutively active STIM.  
This would refute any criticism that non-specific pharmacological ER stressors may be 
activating other cellular processes that could contribute to the observed response. 
 
Another interpretation of the negative electrophysiological result in the STIM-KD 
experiment is that STIM proteins do not play a role in neuronal ER stress induced 
pannexin activation. To consider this interpretation, we need a positive control to 
functionally confirm the knock down of STIM proteins upon lentiviral infection of 
shRNASTIM1&2.   This can be confirmed by using calcium imaging to assay for store-
operated calcium entry after the shRNA knock down of STIM.  Since store-operated Ca2+ 
entry is contingent on STIM proteins we should not observe any store-operated Ca2+ 
entry in shRNASTIM1&2 infected neurons (Liou et al., 2005; Roos et al., 2005).  This result 
would add confidence in the negative finding resulting from STIM knockdown 
experiments and would allow me to reject my hypothesis of STIM-pannexin coupling in 
the context of neuronal ER stress induced pannexin activation.  To avoid skepticism 
towards effectiveness of the knock down, an ideal experiment to test my hypothesis 
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would be to record ER stress induced pannexin activation in neurons from STIM 
knockout mice.  
 
A recent study highlighting pannexin involvement in an in vivo model of cerebral 
ischemia used pannexin-1-/-, pannexin-2-/- and pannexin-1-/-pannexin-2-/- knockout mice 
to determine the contribution of each form to neuronal cell death.  Interestingly, 
pannexin-1-/-pannexin-2-/- knockout mice demonstrated smaller infarct sizes and increased 
cell viability, whereas damage in pannexin-1-/- and pannexin-2-/- was the same as in wild-
type mice (Bargiotas et al., 2011).  To further my own findings, I would record ER stress 
induced currents from pannexin-1 knockout mice to understand whether or not there is 
any contribution by pannexin-2 to the aforementioned ER stress induced pannexin 
activation. 
 
Furthermore, now that I have shown pannexin activation in response to Aβ42 treatment, a 
future study would be to repeat that experiment in neuronal cultures from pannexin-1 
knockout mice.  I would expect the constitutive current observed at the onset of the 
recording to be abolished.  This would provide rationale for a cell death assay to 
investigate the relative Aβ42-mediated neurotoxicity in pannexin-1 knockout neurons 
compared to wild-type neurons.  This set of experiments would add to the significance of 
the project by characterizing a role for pannexin channel activation in AD.  
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4.8 Significance of the study 
The importance of my study is highlighted by the limited information on the regulation of 
pannexin channel activity.  Despite numerous findings of novel pannexin channel 
function, very few studies have examined molecular mechanisms underlying pannexin 
activation.  My findings do not refute any of the previous implications for pannexin 
channel involvement in various pathophysiological conditions; rather it adds another 
possible mechanism of activation for the field to consider.  In this project, I have 
established ER stress as a means of activating pannexin channels, not to be 
misunderstood for proposing a novel function of pannexin channels.  Accordingly, my 
finding implicates pannexin channels as a downstream mediator of the ER stress 
response. It is entirely possible that the pannexin activation demonstrated by other groups 
in various contexts including inflammation, apoptosis and hypoxia is a downstream effect 
of the ER stress that is associated with these conditions. 
 
Broader implications of my study stem from the involvement of ER stress in 
neurodegeneration.  By presenting evidence of pannexin activation in a model of 
Alzheimer’s Disease, the contribution of pannexin channels to neurotoxicity and the 
disruption of the ER stress-pannexin coupling in neurodegeneration becomes a focal 
point for future projects.  
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Appendix A: Supplementary Figures 
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Figure S1.  Unpublished lab data illustrating A) various pharmacological ER stress 
inducers activating La3+ sensitive currents in neurons. B) Pharmacological profile of 
ER stress induced currents rule-in pannexin channels and rule-out other non-
selective cation channels in neurons. 
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Figure S2.  Unpublished lab data. Western blot characterization of Aβ42 oligomers 
composed as trimers and tetramers. 
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Figure S3.  Unpublished lab data illustrating that complete reconstitution of 
thapsigargin-evoked current in HEK cells requires co-transfection of pannexin-1 
and either STIM1 or STIM2. 
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Figure S4.  Unpublished lab data demonstrating the effectiveness of RNAi 
knockdown of STIM1 and STIM2, following lentiviral infection in neurons, by 
Western blot and quantified densitometrically (normalized to β-actin). 
  
	   	   81
  
	  
Appendix B: Curriculum Vitae 
     Ankur Bodaila 
Education  
Western University: Masters of Science in Pharmacology and Toxicology                     
Sept. 2011- Sept. 2013 
Thesis: ER stress coupled pannexin activation via STIM proteins 
Supervisors: Drs. Michael F. Jackson and John F. MacDonald 
 
Western University: Bachelor of Sciences (Honors Specialization in Medical Sciences) 
Sept. 2007 – Apr. 2011 
 
Scholarships and Awards 
First Place – Neuroscience & Mental Health – London Health Research Day 2013   
Mar. 2013 
o Poster presentation titled “ER stress induced pannexin activation via STIM coupling” 
Western University Graduate Thesis Research Award – Travel Scholarship       
Jan. 2013 
o Value: $500   Duration:  Jan. 2013 – Aug. 2013 
Alzheimer’s Foundation of London and Middlesex Scholarship – M.Sc. Award    
Nov. 2012 
o Value: $12 500  Duration:  Sept. 2012 – Aug. 2013 
First Place – Neuroscience – Dept. of Physiology & Pharmacology Research Day   
Nov. 2012 
o Poster presentation titled “ER stress induced pannexin activation via STIM coupling” 
 
Teaching Experience 
Western University – Department of Physiology & Pharmacology           
2012-2013 Mammalian Physiology 3130Y – Course Coordinator: Thomas Stavraky  
2011-2012 Mammalian Physiology 3130Y – Course Coordinator: Thomas Stavraky 
 
Publications 
Bodalia A, Li H, Jackson MF (2012) Loss of endoplasmic reticulum Ca2+ homeostasis: 
contribution to neuronal cell death during cerebral ischemia. Acta Pharmacologica Sinica. 
34(1): 49-59. Review. 
